impress cost manag
result beat expect buy maintain
report strong result exceed expect
compani deliv good revenu growth across market continu
demonstr impress cost manag maintain posit outlook
compani earn support grow awar osa
increas penetr current market expans new market
increas rate mask replenish growth saa busi
continu rate stock buy given posit earn outlook high
report result exceed forecast revenu
vs dbe underli ebit vs dbe
underli npat vs dbe america segment achiev
consist revenu growth previou quarter row segment deliv
strong growth devic experienc slower mask accessori growth
compani perform well cost control better expect
outcom gross margin sg
revis estim follow result lower
brightre revenu forecast increas row devic revenu
lower row mask accessori revenu increas
gm assumpt lower sg assumpt
reduc capital-expenditure forecast net impact ep chang
valuat risk
revis tp deriv use dcf valuat
methodolog dcf use wacc coe d/ev
key downsid risk includ advers chang reimburs
price oct
multipl yield calcul use averag histor price past year spot price current futur year except price-to-book use
year end close
distribut gmt
deutsch bank seek busi compani cover research report thu investor
awar firm may conflict interest could affect object report investor
consid report singl factor make invest decis disclosur analyst
run number
global
develop
manufactur distribut market medic
devic cloud-bas softwar applic
diagnos treat manag respiratori disord xd
flow oper
net inc/ dec borrow
chang work capit
cash equival
properti plant equip
 tax effect
revis estim follow result lower
brightre revenu forecast increas row devic revenu
lower row mask accessori revenu
increas gm assumpt
lower sg assumpt
reduc capital-expenditure forecast
net impact ep chang
report result exceed forecast revenu
vs dbe underli ebit vs dbe
underli npat vs dbe
highlight result includ
currenc group revenu growth stronger last
two quarter note continu grow faster competitor
acceler growth contrast philip report slowdown
america segment america segment report revenu
vs pcp broadli line dbe devic revenu
growth stabl vs
line dbe mask accessori revenu growth remain strong
vs slightli lower dbe
rest world segment row segment report revenu
cc growth vs pcp came dbe row devic cc
growth higher dbe manag attribut
patient upgrad telemonitor devic row devic growth
slow manag believ due upgrad cycl
mostli play franc howev manag said row
sale growth show upgrad cycl longer tail previous
thought row mask accessori cc growth dbe
manag believ
row mask
accessori thought growth line
industri manag said take longer new product permeat
europ expect new launch past month lift
figur rest world revenu growth
brightre brightre report revenu vs pcp
line dbe manag said brightre growth exclud
acquisit healthcarefirst high singl digit lower
doubl digit growth rate previous achiev manag said
growth impact integr healthcarefirst expect
growth recov
devic global devic growth ahead forecast
improv achiev
mask accessori growth global mask accessori growth
forecast came lower achiev
gross margin gross margin ahead dbe
margin manag guid gross
margin broadli consist gross margin
sg sg expens vs pcp broadli
line dbe sg percentag sale
slightli dbe manag maintain
guidanc sg rang
 expens vs pcp slightli
higher dbe percentag sale
larg line dbe manag maintain
guidanc rang
underli ebit underli ebit came vs dbe
pcp translat ebit margin vs dbe
pcp
sale octob
tax tax higher dbe impli
tax rate vs dbe manag maintain guidanc
tax rate
net debt compani report net debt sep vs dbe
jun
net debt higher expect wrong time
acquisit healthcarefirst gear increas sep vs
dbe jun
cash-flow compani report opcf vs dbe
pcp howev weaker expect opcf due tax
payment ebitda cash convers ratio quarter remain strong
vs dbe
capital-expenditure compani report capital-expenditure vs dbe
pcp
dividend board declar dividend vs dbe
pcp
sg sale
 sale
valuat risk
target price prev base dcf
valuat use three-stag dcf model discount post-tax free cash
flow target price increas due increas earn
wacc assum beta coe risk-fre rate
premium target d/ev forecast explicit cash flow
follow horizon period cash flow growth fade
long-term termin valu growth rate set termin
growth rate slight premium nomin global estim reflect
long term demand trend rmd osa product
signific reduct product fund reimburs
new innov product releas competitor lead market
elev price pressur increas competit
